Article
The Future of US Pharma: Key Factors Shaping the Next 12 Months
The US pharmaceutical sector is poised for a year of transformation, driven by a confluence of regulatory shifts, technological advancements, economic pressures, and the increasing adoption of automation. As the industry navigates these changes, automation, particularly in the generation of Certificates of Analysis (COAs), will play a critical role in shaping the sector's trajectory over the ne...